Autopsy report · NCT00775606

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

“Study stopped 12/2010 due to poor enrollment. Only 15 of 60 needed enrolled.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 3 months before it stopped.
• 15 participants enrolled.
• Results were posted on the registry 3 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Rush University Medical Center

Sponsor type

University, hospital or other

Conditions

Acquired Immune Deficiency Syndrome

Interventions

Lopinavir 400 mg/ritonavir 100 mg; Efavirenz

Participants

15

Sites

4

Countries

United States

Trials that died the same way

• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (84% match in meaning)
• Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
  “This study was stopped due to poor enrollment numbers” (83% match in meaning)
• Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
  “This study was stopped prematurely due to lack of enrollment within a 1-5-year period.” (82% match in meaning)
• The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
  “Due to lower than anticipated enrollment number, this study was stopped.” (81% match in meaning)
• Salvage Cryotherapy in Recurrent Prostate Cancer
  “Study was ended due to low enrollment” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.